Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate as adjunct to NRT for smoking cessation
NCT00208858Phase 2Completed
- Sponsor
- Emory University
- Start
- Dec 2004
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of topiramate in Tobacco Use Disorder (TUD), sponsored by Emory University. Primary endpoint: Neural correlates of nicotine craving at 12 weeks. Started Dec 2004; status: completed.
02
Drugs
topiramate
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00208858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208858.